JGC
CBAY
J. Goldman & Co’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-165,937
| Closed | -$3.92M | – | 427 |
|
|
2023
Q4 | $3.92M | Buy |
165,937
+26,988
| +19% | +$637K | 0.16% | 99 |
|
|
2023
Q3 | $2.07M | Buy |
+138,949
| New | +$2.07M | 0.07% | 134 |
|
|
2019
Q2 | – | Sell |
-153,298
| Closed | -$2.04M | – | 263 |
|
|
2019
Q1 | $2.04M | Buy |
+153,298
| New | +$2.04M | 0.11% | 100 |
|
|
2018
Q4 | – | Sell |
-41,912
| Closed | -$464K | – | 238 |
|
|
2018
Q3 | $464K | Sell |
41,912
-68,022
| -62% | -$753K | 0.03% | 132 |
|
|
2018
Q2 | $1.48M | Sell |
109,934
-345,666
| -76% | -$4.64M | 0.08% | 144 |
|
|
2018
Q1 | $5.92M | Sell |
455,600
-103,400
| -18% | -$1.34M | 0.25% | 64 |
|
|
2017
Q4 | $5.14M | Buy |
559,000
+26,000
| +5% | +$239K | 0.27% | 56 |
|
|
2017
Q3 | $4.3M | Sell |
533,000
-255,125
| -32% | -$2.06M | 0.22% | 70 |
|
|
2017
Q2 | $4.54M | Buy |
788,125
+62,125
| +9% | +$358K | 0.25% | 62 |
|
|
2017
Q1 | $3.12M | Buy |
726,000
+395,793
| +120% | +$1.7M | 0.15% | 99 |
|
|
2016
Q4 | $571K | Buy |
+330,207
| New | +$571K | 0.04% | 158 |
|
|
2016
Q2 | – | Sell |
-239,260
| Closed | -$323K | – | 303 |
|
|
2016
Q1 | $323K | Sell |
239,260
-117,000
| -33% | -$158K | 0.02% | 164 |
|
|
2015
Q4 | $602K | Sell |
356,260
-3,240
| -0.9% | -$5.48K | 0.06% | 136 |
|
|
2015
Q3 | $697K | Buy |
+359,500
| New | +$697K | 0.06% | 126 |
|